Shifting its policy, the United States has agreed to allow companies to export to India raw materials needed for vaccines. The raw materials had been prioritized for making vaccines in the US. But the shift in policy comes amid an outbreak in India that is pushing that country’s health system to the brink. Host Marco Werman speaks with Matt Kavanagh, an assistant professor of global health at Georgetown University, about the backlogs and the role of the US.
The story you just read is available to read for free because thousands of listeners and readers like you generously support our nonprofit newsroom. Every day, the reporters and producers at The World are hard at work bringing you human-centered news from across the globe. But we can’t do it without you: We need your support to ensure we can continue this work for another year.
When you make a gift of $10 or more a month, we’ll invite you to a virtual behind-the-scenes tour of our newsroom to thank you for being with The World.